Tissue Repair in Osteoradionecrosis Using Pentoxifylline and Tocopherol--report of Three Cases

Overview

Journal Oral Maxillofac Surg

Specialties Dentistry
General Surgery

Date 2015 Aug 8

PMID 26251132

Citations 5

Authors

Joslei Carlos Bohn

Juliana Lucena Schussel

Roberta Targa Stramandinoli-Zanicotti

Laurindo Moacir Sassi

Affiliations

Soon will be listed here.

Abstract

Purpose: Osteoradionecrosis is a complication of head and neck radiotherapy, with a difficult resolution and no well-established treatment. The disease progression can cause important loss on patient's quality of life after cancer treatment. The options for treatment are limited and include clinical monitoring, prescription, or surgical procedures. As an alternative for bone necrosis treatment, a combination of drugs, pentoxifylline and tocopherol, can be used. Studies have shown that this combination significantly reduces chronic radiotherapy damage. The article reports successful treatment with this prescription protocol.

Methods: We report three cases of patients referred to the Service of Oral and Maxillofacial Surgery at Erasto Gaertner Hospital, in Curitiba, Brazil. They were submitted to radiotherapy for the treatment of malignant head and neck tumors and later developed osteoradionecrosis. They were treated with the combination pentoxifylline and tocopherol.

Results: All patients achieved complete remission in less than 1 year, with complete healing of bone exposure and without clinical symptoms.

Conclusions: This results show that this combination of drugs is beneficial in cases of bone necrosis induced by radiation, avoiding more aggressive treatments and reducing morbidity.

Citing Articles

Aguiar I, Carvalho F, Santos-Lins L, Brasil-Oliveira R, Brites C, Cotrim H Med Oral Patol Oral Cir Bucal. 2023; 28(4):e310-e316.

PMID: 36641744 PMC: 10314354. DOI: 10.4317/medoral.25731.

Pentoxifylline and tocopherol for the treatment of osteoradionecrosis of the jaws. A systematic review.

Arqueros-Lemus M, Marino-Recabarren D, Niklander S, Martinez-Flores R, Moraga V Med Oral Patol Oral Cir Bucal. 2023; 28(3):e293-e300.

PMID: 36641743 PMC: 10181025. DOI: 10.4317/medoral.25729.

Outcome of stereotactic body radiation for treatment of nasal and nasopharyngeal lymphoma in 32 cats.

Reczynska A, LaRue S, Boss M, Lee B, Leary D, Pohlmann K J Vet Intern Med. 2022; 36(2):733-742.

PMID: 35188694 PMC: 8965259. DOI: 10.1111/jvim.16388.

Postradiation Fractures after Combined Modality Treatment in Extremity Soft Tissue Sarcomas.

Bartelstein M, Yerramilli D, Christ A, Kenan S, Ogura K, Fujiwara T Sarcoma. 2021; 2021:8877567.

PMID: 33790687 PMC: 7984930. DOI: 10.1155/2021/8877567.

The effects of pentoxifylline adminstration on fracture healing in a postmenopausal osteoporotic rat model.

Vashghani Farahani M, Ahadi R, Abdollahifar M, Bayat M Lab Anim Res. 2017; 33(1):15-23.

PMID: 28400835 PMC: 5385278. DOI: 10.5625/lar.2017.33.1.15.

References

Annane D, Depondt J, Aubert P, Villart M, Gehanno P, Gajdos P . Hyperbaric oxygen therapy for radionecrosis of the jaw: a randomized, placebo-controlled, double-blind trial from the ORN96 study group. J Clin Oncol. 2004; 22(24):4893-900. DOI: 10.1200/JCO.2004.09.006. View

Delanian S, Lefaix J . Complete healing of severe osteoradionecrosis with treatment combining pentoxifylline, tocopherol and clodronate. Br J Radiol. 2002; 75(893):467-9. DOI: 10.1259/bjr.75.893.750467. View

Mendenhall W . Mandibular osteoradionecrosis. J Clin Oncol. 2004; 22(24):4867-8. DOI: 10.1200/JCO.2004.09.959. View

Schwartz H, Kagan A . Osteoradionecrosis of the mandible: scientific basis for clinical staging. Am J Clin Oncol. 2002; 25(2):168-71. DOI: 10.1097/00000421-200204000-00013. View

Williamson R, Kondziolka D, Kanaan H, Lunsford L, Flickinger J . Adverse radiation effects after radiosurgery may benefit from oral vitamin E and pentoxifylline therapy: a pilot study. Stereotact Funct Neurosurg. 2008; 86(6):359-66. DOI: 10.1159/000163557. View

Wahl M . Osteoradionecrosis prevention myths. Int J Radiat Oncol Biol Phys. 2006; 64(3):661-9. DOI: 10.1016/j.ijrobp.2005.10.021. View

Delanian S, Lefaix J . Current management for late normal tissue injury: radiation-induced fibrosis and necrosis. Semin Radiat Oncol. 2007; 17(2):99-107. DOI: 10.1016/j.semradonc.2006.11.006. View

Marques L, Zheng L, Poulakis N, Guzman J, Costabel U . Pentoxifylline inhibits TNF-alpha production from human alveolar macrophages. Am J Respir Crit Care Med. 1999; 159(2):508-11. DOI: 10.1164/ajrccm.159.2.9804085. View

Berman B, Duncan M . Pentoxifylline inhibits the proliferation of human fibroblasts derived from keloid, scleroderma and morphoea skin and their production of collagen, glycosaminoglycans and fibronectin. Br J Dermatol. 1990; 123(3):339-46. DOI: 10.1111/j.1365-2133.1990.tb06294.x. View

10.

Mandell G . Cytokines, phagocytes, and pentoxifylline. J Cardiovasc Pharmacol. 1995; 25 Suppl 2:S20-2. DOI: 10.1097/00005344-199500252-00005. View

11.

Rubin P, Johnston C, Williams J, McDonald S, Finkelstein J . A perpetual cascade of cytokines postirradiation leads to pulmonary fibrosis. Int J Radiat Oncol Biol Phys. 1995; 33(1):99-109. DOI: 10.1016/0360-3016(95)00095-G. View

12.

Balogh J, Sutherland S . Osteoradionecrosis of the mandible: a review. J Otolaryngol. 1989; 18(5):245-50. View

13.

Rice N, Polyzois I, Ekanayake K, Omer O, Stassen L . The management of osteoradionecrosis of the jaws--a review. Surgeon. 2014; 13(2):101-9. DOI: 10.1016/j.surge.2014.07.003. View

14.

Robard L, Louis M, Blanchard D, Babin E, Delanian S . Medical treatment of osteoradionecrosis of the mandible by PENTOCLO: preliminary results. Eur Ann Otorhinolaryngol Head Neck Dis. 2014; 131(6):333-338. DOI: 10.1016/j.anorl.2013.11.006. View

15.

Lefaix J, Delanian S, Vozenin M, Leplat J, Tricaud Y, Martin M . Striking regression of subcutaneous fibrosis induced by high doses of gamma rays using a combination of pentoxifylline and alpha-tocopherol: an experimental study. Int J Radiat Oncol Biol Phys. 1999; 43(4):839-47. DOI: 10.1016/s0360-3016(98)00419-2. View

16.

Okunieff P, Augustine E, Hicks J, Cornelison T, Altemus R, Naydich B . Pentoxifylline in the treatment of radiation-induced fibrosis. J Clin Oncol. 2004; 22(11):2207-13. DOI: 10.1200/JCO.2004.09.101. View

17.

Silverman Jr S . Oral cancer: complications of therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999; 88(2):122-6. DOI: 10.1016/s1079-2104(99)70103-4. View

18.

Almazrooa S, Woo S . Bisphosphonate and nonbisphosphonate-associated osteonecrosis of the jaw: a review. J Am Dent Assoc. 2009; 140(7):864-75. DOI: 10.14219/jada.archive.2009.0280. View

19.

Balazs C, Kiss E . Immunological aspects of the effect of pentoxifylline (Trental) (a brief review). Acta Microbiol Immunol Hung. 1994; 41(2):121-6. View

20.

Rothwell B . Prevention and treatment of the orofacial complications of radiotherapy. J Am Dent Assoc. 1987; 114(3):316-22. DOI: 10.14219/jada.archive.1987.0066. View